HOYA Corporation (TYO:7741)
Japan · Delayed Price · Currency is JPY 19,040
-465 (-2.38%)
Jul 29, 2025, 3:30 PM JST
HOYA Corporation Revenue
In the fiscal year ending March 31, 2025, HOYA Corporation had annual revenue of 866.03B JPY with 13.56% growth. HOYA Corporation had revenue of 215.59B in the quarter ending March 31, 2025, with 14.58% growth.
Revenue
866.03B
Revenue Growth
+13.56%
P/S Ratio
7.54
Revenue / Employee
22.85M
Employees
37,909
Market Cap
6,526.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 866.03B | 103.42B | 13.56% |
| Mar 31, 2024 | 762.61B | 39.03B | 5.39% |
| Mar 31, 2023 | 723.58B | 62.12B | 9.39% |
| Mar 31, 2022 | 661.47B | 113.55B | 20.72% |
| Mar 31, 2021 | 547.92B | -28.63B | -4.96% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |
| Olympus | 997.33B |